Medtronic’s Micra AV Receives the US FDA’s Approval as the World’s Smallest Pacemaker to Treat AV Block

 Medtronic’s Micra AV Receives the US FDA’s Approval as the World’s Smallest Pacemaker to Treat AV Block

Medtronic’s Micra AV Receives the US FDA’s Approval as the World’s Smallest Pacemaker to Treat AV Block

Shots:

  • The approval is based on MARVEL 2 study evaluating the ability of the Micra’s internal sensor, monitoring atrial contractions and enable coordinated pacing between the atrium and ventricle thus providing AV synchrony pacing therapy to patients with AV block
  • The MARVEL 2 study demonstrated a greater percentage of complete heart block patients with normal sinus rhythm having >70% AV synchrony during algorithm-mediated AV synchronous pacing than VVI pacing, showed no pauses/ episodes of pacing-induced tachycardia
  • Medtronic’s Micra AV is the first and only FDA-approved leadless pacemaker, has shown 63% reduction in major complication and does not require leads or a surgical “pocket” under the skin

Click here ­to­ read full press release/ article | Ref: GlobeNewswire | Image: Medtronic

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post